Results 191 to 200 of about 9,058 (209)
Some of the next articles are maybe not open access.

Efficacy and safety of desloratadine in the treatment of perennial allergic rhinitis

Journal of Allergy and Clinical Immunology, 2003
The evidence base for the use of H1-antihistamines in the treatment of perennial allergic rhinitis is considerably smaller than it is in the treatment of seasonal allergic rhinitis.We hypothesized that desloratadine, a new, nonsedating selective H1-antihistamine, would be efficacious and safe in the treatment of perennial allergic rhinitis.In a ...
F. Estelle R. Simons   +2 more
openaire   +3 more sources

Evaluation of allergic etiology in perennial rhinitis.

Annals of allergy, 1985
In 197 patients with perennial rhinitis, 49 patients (24.9%) were found to be allergic to perennial inhalant allergens, 37 patients (18.8%) allergic to seasonal allergens, 52 patients (26.4%) had food intolerance, 12 patients (6.6%) showed evidence of nasal infection, and in 46 patients (23.3%) etiology was undetermined.
E.A. Pastorello   +7 more
openaire   +2 more sources

Evaluation of the palate dimensions of patients with perennial allergic rhinitis

International Journal of Paediatric Dentistry, 2001
Summary.Objective. The purpose of this study was to compare the transverse and vertical palate dimensions of two groups of children, one diagnosed as having perennial allergic rhinitis (PAR) and the other without any respiratory pathology.Design. Case‐control study.Setting.
L. S. G. Primo   +3 more
openaire   +3 more sources

Evaluation of the efficacy and safety of loratadine in perennial allergic rhinitis

Journal of Allergy and Clinical Immunology, 1989
Loratadine, a new nonsedating antihistamine, was evaluated for efficacy and safety in 228 patients with perennial allergic rhinitis. Taken at a dose of 10 mg once daily, loratadine was significantly more effective than placebo and comparable to terfenadine, 60 mg taken twice daily, in reducing combined symptom scores in this patient population ...
Gert Kunkel   +5 more
openaire   +2 more sources

The pharmacological basis for the treatment of perennial allergic rhinitis and non‐allergic rhinitis with topical corticosteroids

Allergy, 1997
The currently available respiratory topical corticosteroids are all effective at reducing the nasal symptoms of itch, sneezing, rhinorrhoea and obstruction associated with allergic rhinitis. The mechanism of action of corticosteroids is related to their anti‐innammatory activities.
openaire   +3 more sources

Fexofenadine reduces nasal congestion in perennial allergic rhinitis

Allergy, 2001
Background: Nasal congestion is the predominant symptom in perennial allergic rhinitis (PAR), and it seems to be mainly related to the late‐phase inflammatory events. The present pilot study aimed to evaluate the therapeutic effect exerted by fexofenadine in patients with PAR due to mite allergy.
C. Mondino   +4 more
openaire   +3 more sources

Etiopathogenesis and Management of Perennial Allergic Rhinitis

Treatments in Respiratory Medicine, 2004
Perennial allergic rhinitis is an inflammatory disorder characterized by symptoms of nasal congestion, rhinorrhea, sneezing, and itching. The prevalence of allergic rhinitis is quite common and affects 20% or more of various populations. Some patients with allergic rhinitis are symptomatic only during the pollen season, while many others are allergic ...
openaire   +3 more sources

Desloratadine therapy for symptoms associated with perennial allergic rhinitis

Annals of Allergy, Asthma & Immunology, 2006
Perennial allergic rhinitis (PAR) has a substantial negative social and economic impact. Recent studies emphasize the potential seriousness of PAR and the need for improved treatment of this condition.To confirm the efficacy and safety of the H1-antihistamine desloratadine in reducing the symptoms of PAR in a randomized, double-blind, placebo ...
Barry N. Lutsky   +5 more
openaire   +3 more sources

Perennial allergic rhinitis: Clinical efficacy of a new antihistamine [PDF]

open access: possibleJournal of Allergy and Clinical Immunology, 1990
Nasal itching, sneezing, and rhinorrhea are troublesome symptoms in patients with perennial allergic rhinitis. Most first-generation H1-receptor agonists achieve a 50% reduction in these symptoms, but their benefits are frequently offset by annoying anticholinergic and sedative side effects.
openaire   +2 more sources

Soluble Adhesion Molecules and Cytokines in Perennial Allergic Rhinitis

Annals of Allergy, Asthma & Immunology, 1998
Increasing evidence suggests adhesion molecules and cytokines in patients with inflammatory airway diseases are involved in steps of entrapment and migration of inflammatory cells. Recently, soluble forms of adhesion molecules and cytokines have been detected in the sera and other body fluids of patients with various diseases.Eosinophilia in nasal ...
Yuan-Kai Cheng   +2 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy